Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

C4 Therapeutics (CCCC) Other Non Operating Income (2019 - 2023)

Historic Other Non Operating Income for C4 Therapeutics (CCCC) over the last 3 years, with Q3 2023 value amounting to -$621000.0.

  • C4 Therapeutics' Other Non Operating Income changed N/A to -$621000.0 in Q3 2023 from the same period last year, while for Dec 2024 it was -$621000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of -$621000.0 for FY2023, which is N/A changed from last year.
  • Latest data reveals that C4 Therapeutics reported Other Non Operating Income of -$621000.0 as of Q3 2023.
  • C4 Therapeutics' 5-year Other Non Operating Income high stood at $43000.0 for Q3 2020, and its period low was -$621000.0 during Q3 2023.
  • In the last 3 years, C4 Therapeutics' Other Non Operating Income had a median value of -$1000.0 in 2019 and averaged -$193000.0.
  • Over the last 5 years, C4 Therapeutics' Other Non Operating Income had its largest YoY gain of 440000.0% in 2020, and its largest YoY loss of 440000.0% in 2020.
  • C4 Therapeutics' Other Non Operating Income (Quarter) stood at -$1000.0 in 2019, then soared by 4400.0% to $43000.0 in 2020, then crashed by 1544.19% to -$621000.0 in 2023.
  • Its Other Non Operating Income was -$621000.0 in Q3 2023, compared to $43000.0 in Q3 2020 and -$1000.0 in Q3 2019.